Ozempic Stomach Paralysis, Intestinal Blockage & Blood Clot Lawsuits
Lawsuits Filed by Users of Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound
RPWB lawyers are filing lawsuits on behalf of individuals who developed stomach paralysis (called gastroparesis), ileus/intestinal blockage, deep vein thrombosis, blood clots or pulmonary embolism after using GLP-1RA drugs. These drugs, better known by the names Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound, are used to manage diabetes and for weight loss.
As the popularity of Ozempic, Mounjaro and similar drugs rises, complaints that the drugs are causing serious gastrointestinal injuries including gastroparesis, or stomach paralysis, have also been coming to the surface. As of February 2024, about five dozen lawsuits had been filed in federal court. They were consolidated in the Eastern District of Pennsylvania, where the litigation will take place. Some estimates indicate that as many as 10,000 users of weight loss drugs have developed or have the potential to develop gastroparesis and other severe side effects such as intestinal blockage, blood clots or pulmonary embolism.
The makers of Ozempic and the other drugs do not currently disclose that gastroparesis is a possible side effect. We believe that it is wrong to mislead doctors and patients by omitting common side effects.
If you or a loved one developed gastroparesis, or stomach paralysis, after using weight loss drugs, please call us to begin your free, no-obligation case review. You may be entitled to significant compensation. Your participation also helps keep the pharmaceutical industry honest with their marketing to patients and doctors.
RPWB attorneys are known for their work on behalf of pharmaceutical patients who suffer from severe side effects. Our law firm is a 2024 Best Law Firm as rated by Best Lawyers and is a 2023 U.S. News & World Report Best Law Firm. RPWB has served as lead counsel in 7 national pharmaceutical and medical device lawsuits, and has helped thousands of people nationwide.
Start Your Free Weight Loss Drug Lawsuit Case Review
Or you may call us at 1-866-639-0366.
Ozempic, Mounjaro and Similar Drugs’ Impact on Digestion
Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound are nearly identical diabetes and weight loss drugs made by the same manufacturers, Novo Nordisk and Eli Lilly. The drugs are mostly administered by injection under the skin, usually once per week. However, Rybelsus comes in pill form and is administered orally. They are known as GLP-1 receptor agonists, a class of drugs that reduce blood sugar and energy intake by mimicking the actions of a hormone that is released by the body after eating. Patients report feeling full despite not consuming as much food as they normally do.
One of the roles of GLP-1 is to slow the passage of food through the stomach, which helps people feel fuller longer. However, if the stomach slows down too much, it causes problems. Gastroparesis occurs when the stomach is no longer processing food at an appropriate speed. It causes nausea, vomiting and abdominal pain. It can also cause problems with blood sugar levels, nutrition and dehydration. The slowdown in processing food can also lead to intestinal blockages.
There’s nothing on the labels of Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound that specifically cautions about the possibility of developing gastroparesis. For some people, the gastroparesis subsides after use of the drug is discontinued, but for others the painful condition persists. It sometimes requires hospitalization.
Recently, the American Society of Anesthesiologists has acknowledged the drug’s impact on digestion. The organization warned that patients should stop using Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound a week before surgery. The drugs can increase the risk that patients will aspirate — or regurgitate food — during an operation, even if they have fasted. Vomiting under anesthesia can cause food and stomach acid to get into the lungs, a cause of pneumonia and other problems.
Despite some of the negative aspects of the drug, sales of Ozempic and Wegovy have taken off in recent years thanks to an aggressive marketing campaign on television and social media that has highlighted the drugs for their role in helping people lose weight. In the first nine months of 2023, Ozempic brought in $9.4 billion in revenue, an increase of 59 percent from the same period in 2022. Wegovy’s sales increased 730 percent.
Eli Lilly, meanwhile, has experienced similar financial success, especially with Mounjaro, which brought in $5 billion in sales in 2023, the drug’s first full year on the market.
The success has prompted Novo Nordisk and Eli Lilly to upgrade their financial projections for the coming years. But they haven’t yet updated the warning label and literature about the drugs’ potential side effects.
Our Experienced Lawyers
How can we help? Fill out the form for a free case review.
Contact Us
- Toll Free: 888.293.6883
Case Types
Related Posts
Mar 22, 2024
Asbestos Finally Banned in United States
We’ve been waiting nearly 50 years to type this: Asbestos is finally banned in the United States. After decades of inadequate protections for workers, the EPA has finally banned the only remaining type of asbestos still imported into America. More than 50 countries have already banned the use of asbestos, which is known to cause […]
READ MOREJan 22, 2024
Gordon Rhea Wins USVI Bar Association’s Highest Honor
RPWB of counsel attorney Gordon Rhea was honored with the highest award during the Virgin Islands Bar Association’s annual meeting on December 8, 2023. The award ceremony highlighted Rhea’s dedication to the legal profession and his commitment, dedication and valuable contributions to the people of the Virgin Islands. The Winston A. Hodge Award for Public […]
READ MORENov 27, 2023
RPWB Represented a Whistleblower who Helped the Federal Government Recoup $1.7 million
ORLANDO, Fla. – The federal government has recouped $1.7 million from a healthcare provider who fraudulently billed Medicare and TRICARE for medical procedures that were not deemed necessary and were performed by an unqualified technician. In the settlement agreement, Jena Medical Group LLC, as well as several individuals associated with the company, have agreed to […]
READ MOREOct 17, 2023
Local Non-Profit to Receive $500,000 to Help Low Income Households Save Money on Power Bills
CHARLESTON, S.C. – A local energy conservation non-profit will receive nearly $500,000 to help low income residents in Berkeley, Georgetown and Horry counties conserve energy and save money on energy bills. The Sustainability Institute will receive $484,345.89 in unclaimed monies from the 2021 settlement of the class action lawsuit Hearn v. Santee Cooper. The case […]
READ MOREOct 02, 2023
RPWB Announces the Passing of J. David Butler
It is with great sorrow and heavy hearts that we announce the passing of our friend, colleague and law partner, J. David Butler on September 30, 2023, after a valiant three-year battle with cancer. He was a friend to all and was, quite simply, the nicest guy one could have the pleasure of knowing. Dave […]
READ MOREAug 21, 2023
17 RPWB Attorneys Selected for Best Lawyers in America List
MOUNT PLEASANT, S.C – Seventeen RPWB attorneys were selected for the 2024 edition of The Best Lawyers in America® list for numerous practice areas including personal injury, product liability, mass tort, class action, qui tam and medical malpractice litigation. This marks the seventh consecutive year in which RPWB is the top-listed plaintiff law firm in […]
READ MOREMay 01, 2023
Trial Lawyer Deon Tedder Joins RPWB
Trial attorney Deon Tedder has joined Rogers, Patrick, Westbrook & Brickman, LLC, where he will focus on personal injury, mass torts and criminal defense work out of the firm’s Mount Pleasant and Columbia offices. Tedder joins RPWB after working at David Aylor Law Offices for the past five years, where he helped many clients in […]
READ MOREFeb 03, 2023
Johnson & Johnson Talc Bankruptcy Petition Dismissal is a Win for Mesothelioma and Ovarian Cancer Victims
By Dave Butler In a significant victory for injured consumers, the Third Circuit Court of Appeals dismissed the bankruptcy petition of a Johnson & Johnson subsidiary that holds the company’s liabilities for claims brought by thousands of consumers injured by exposure to asbestos-contaminated talc in Johnson & Johnson products. The dismissal, on January 30, 2023, […]
READ MORENov 03, 2022
U.S. News & World Report: RPWB is a Top National Law Firm for Mass Torts & Class Actions
CHARLESTON, S.C. — RPWB is incredibly proud to be selected as one of the top national law firms for mass torts and class actions by U.S. News & World Report. RPWB is officially listed as a Tier 1 law firm for such cases, the highest possible designation. In addition to the national selection, RPWB also […]
READ MOREOct 12, 2022
How Do Camp Lejeune Lawsuits Actually Work?
You’ve no doubt seen the ads on television, but did you ever wonder how Camp Lejeune water contamination lawsuits actually work? Our team breaks it down for you. RPWB has filed its first administrative claims with the Navy JAG, the first step in the litigation process under the Camp Lejeune Justice Act. The JAG is tasked […]
READ MOREAug 18, 2022
With Sixteen Attorneys Named to Best Lawyers List, RPWB is the Top-Listed Product Liability and Class Action Law Firm in the State
Sixteen RPWB attorneys were selected for the 2023 edition of The Best Lawyers in America® list for numerous practice areas including personal injury, product liability, mass tort, class action and medical malpractice litigation. This marks the sixth consecutive year in which RPWB is the top-listed plaintiff law firm in South Carolina for both product liability […]
READ MOREAug 10, 2022
With a New Law, Camp Lejeune Water Contamination Victims Finally Have Legal Recourse
For more than 30 years, the drinking water at Marine Corps Base Camp Lejeune was contaminated with a cocktail of dangerous toxins linked to cancer, leukemia, Parkinson’s disease and other serious medical conditions. Now after intense lobbying by veteran’s groups and others, victims of Camp Lejeune’s contaminated water have legal recourse for compensation. On Wednesday, […]
READ MOREAug 03, 2022
Congress Passes Camp Lejeune Water Contamination Law
Over a 34-year period, many thousands of Marines and their families were exposed to dangerous water contamination at Marine Corps Base Camp Lejeune. After a long wait, justice may finally be in sight. Congress approved bi-partisan legislation on Tuesday night that will clear the way for veterans and their families to seek compensation in federal […]
READ MOREJul 05, 2022
Camp Lejeune Water Contamination Law Close to Passing, Would Finally Bring Justice to Veterans and their Families
A bill that is close to becoming law could finally provide justice and financial relief to veterans and their families for health problems caused by water contamination at Camp Lejeune in North Carolina. The bi-partisan Honoring our PACT Act of 2021 has passed both the U.S. Senate and the House of Representatives. It was sent […]
READ MOREJun 21, 2022
RPWB Helped Doctors Get Refunds for Non-Conforming Records Software
RPWB attorneys played a leading role in more than 5,000 doctors’ offices receiving refunds for being misled about their electronic medical record software qualifying for Medicare and Medicaid incentives. For years, Greenway Health sold software it claimed was certified under the federal government’s “Meaningful Use” program. That program includes financial incentives designed to reward physicians […]
READ MORE